T 1437/07 (Botulinum toxin for treating smooth muscle spasm/ALLERGAN) of 26.10.2009

European Case Law Identifier: ECLI:EP:BA:2009:T143707.20091026
Date of decision: 26 October 2009
Case number: T 1437/07
Petition for review of: -
Application number: 99203735.8
IPC class: A61K 38/16
Language of proceedings: English
Distribution: Distributed to board chairmen (C)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Botulinum toxins A or B for treating pain associated with smooth muscle spasms
Applicant name: Allergan, Inc.
Opponent name: Solstice Neurosciences, Inc.
Ipsen Pharma S.A.S.
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54 European Patent Convention Art 56 European Patent Convention Art 76(1)European Patent Convention Art 83 European Patent Convention Art 84
Keywords: Main request - novelty (no)
Auxiliary request - added matter, extension of scope (no); sufficiency of disclosure, novelty, inventive step (yes)
Catchword: -
Cited cases: T 0246/86 T 0158/96 T 0609/02 T 0715/03 T 0630/04
Citing cases: G 0002/21 T 0814/08 T 1457/09 T 0334/10 T 1347/11 T 1175/17 T 0116/18 T 1203/19 T 1045/21 T 0843/22 T 0853/22 T 0969/23

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the auxiliary request as filed during the oral proceedings before the board (claims 1-4 and pages 2-4 of a description adapted thereto).